Prognostic value of cardiac magnetic resonance global T2 mapping in patients with takotsubo syndrome
European Heart Journal - Cardiovascular Imaging

Abstract
Myocardial oedema is a hallmark of takotsubo syndrome (TTS). Cardiac magnetic resonance (CMR) T2 mapping quantifies myocardial oedema, but its prognostic value in TTS is unclear. We evaluated the association between CMR-derived global myocardial T2 and major adverse cardiovascular and cerebrovascular events (MACE).
We retrospectively identified consecutive TTS patients undergoing CMR with tissue mapping within 30 days of admission. Imaging was re-analysed, blinded to clinical data. The primary endpoint was MACE (all-cause death, heart failure hospitalization, recurrent TTS, stroke, or transient ischaemic attack). Time-dependent receiver operating characteristic (ROC) analysis derived a T2 threshold. Prespecified covariates were summarized by ridge-penalized Cox into a single linear predictor for adjustment. A Firth-penalized Cox model tested robustness. Among 110 patients (median age 68 years; 91% women), median global T2 was 56 ms (IQR 53–60), and 17 (15.5%) experienced MACE over a median follow-up of 763 days (IQR 525–1357). T2 ≥ 63 ms predicted 1-year MACE (AUC 0.671, sensitivity 56%, specificity 89%) and separated Kaplan–Meier curves (log-rank
Global myocardial T2 may provide incremental prognostic information beyond prespecified clinical and imaging indices in TTS and refine risk stratification.
Contributors

Jerald Lim
Author

Mohammed Alaqaili
Author

Jamilah Mohammed Al-Harbi
Author

Pape-Mamadou Sene
Author

Mohammed El Mehdi El Yamani
Author

Rebecca E Thornhill
Author

Andrew M Crean
Author
University of Manchester Manchester , United Kingdom of Great Britain & Northern Ireland
You may be interested in






